HOUSTON, Feb. 1, 2021 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary aesthetic platform technology, today announced ...
After securing Food and Drug Administration approval on May 28 for a device that may improve tattoo removal, shares of Soliton (NASDAQ: SOLY) climbed from $6 per share to over $29 per share on ...
Medical device company Soliton Inc. (NASDAQ: SOLY) has received FDA 510(k) approval for its acoustic wave device for dermal tattoo clearing. Soliton shares were ripping higher by 130.37 percent at $13 ...
HOUSTON, May 28, 2019 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University ...
Soliton pointed out in a regulatory filing this morning that the waiting period mandated under law for deals like AbbVie's acquisition expired Monday night. With that out of the way, Soliton believes ...
(RTTNews) - Allergan Aesthetics, an AbbVie company (ABBV) and Soliton (SOLY) announced Monday a definitive agreement under which Allergan Aesthetics will acquire Soliton and Resonic, its Rapid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results